4//SEC Filing
Simon, Christopher 4
Accession 0001127602-24-023305
CIK 0000313143other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:20 PM ET
Size
5.3 KB
Accession
0001127602-24-023305
Insider Transaction Report
Form 4
Simon, Christopher
DirectorPresident & CEO
Transactions
- Other
Common Stock
2024-08-29$75.56/sh−39,704$3,000,034→ 322,838 total
Footnotes (2)
- [F1]On August 29, 2024, in an asset substitution transaction, Mr. Simon transferred 39,704 shares of the Issuer's common stock to the Simon Family Irrevocable Trust for the benefit of the reporting person's children, in exchange for cash in the amount of $3,000,034, with the number of shares determined by averaging the high and low sales prices of the Issuer's common stock as reported by the New York Stock Exchange on August 29, 2024. The substitution was made in accordance with the terms of the trust, which has an independent trustee.
- [F2]This number includes unvested restricted stock units previously reported.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001674993
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 4:20 PM ET
- Size
- 5.3 KB